UY30237A1 - Inhibidores de la adenilato ciclasa soluble - Google Patents

Inhibidores de la adenilato ciclasa soluble

Info

Publication number
UY30237A1
UY30237A1 UY30237A UY30237A UY30237A1 UY 30237 A1 UY30237 A1 UY 30237A1 UY 30237 A UY30237 A UY 30237A UY 30237 A UY30237 A UY 30237A UY 30237 A1 UY30237 A1 UY 30237A1
Authority
UY
Uruguay
Prior art keywords
adenylate
cycling
inhibitors
soluble
medicines
Prior art date
Application number
UY30237A
Other languages
English (en)
Inventor
Bernd Menzenbach
Bernd Buchmann
Martin Fritsch
Dirk Kosemund
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY30237A1 publication Critical patent/UY30237A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Compuestos de la formula general I, su preparacion y su uso como medicamentos.
UY30237A 2006-03-23 2007-03-23 Inhibidores de la adenilato ciclasa soluble UY30237A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006014319A DE102006014319B4 (de) 2006-03-23 2006-03-23 Inhibitoren der löslichen Adenylatzyklase

Publications (1)

Publication Number Publication Date
UY30237A1 true UY30237A1 (es) 2007-10-31

Family

ID=38438471

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30237A UY30237A1 (es) 2006-03-23 2007-03-23 Inhibidores de la adenilato ciclasa soluble

Country Status (13)

Country Link
US (1) US20070259872A1 (es)
EP (1) EP2001843A2 (es)
JP (1) JP2009530339A (es)
KR (1) KR20090008261A (es)
CN (1) CN101448787A (es)
AR (1) AR060074A1 (es)
CA (1) CA2646594A1 (es)
DE (1) DE102006014319B4 (es)
DO (1) DOP2007000060A (es)
PE (1) PE20080173A1 (es)
TW (1) TW200815348A (es)
UY (1) UY30237A1 (es)
WO (1) WO2007107384A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2036906A1 (de) * 2007-09-05 2009-03-18 Bayer Schering Pharma Aktiengesellschaft Azaindole als Inhibitoren der löslichen Adenylatzyklase
CN108096244B (zh) * 2018-01-25 2020-11-24 昆明医科大学 1-氢-2-吲哚酮-3-苄基/取代苄基-3-甲酸酯类化合物的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544768B1 (en) * 1999-05-11 2003-04-08 Cornell Research Foundation, Inc. Mammalian soluble adenylyl cyclase
AU4018101A (en) * 1999-09-21 2001-04-24 Board Of Trustees Of The Leland Stanford Junior University Polynucleotides encoding human soluble adenylyl cyclase, polypeptides encoded thereby, and methods of use thereof
US20020064849A1 (en) * 2000-09-05 2002-05-30 Herr John C. Human soluble testicular adenylyl cyclase
WO2005070419A1 (en) * 2004-01-21 2005-08-04 Cornell Research Foundation, Inc. Chemical inhibitors of soluble adenylyl cyclase (sac)
DE102004047272A1 (de) * 2004-09-24 2006-04-06 Schering Ag Inhibitoren der löslichen Adenylatzyklase
DE102005027274A1 (de) * 2005-06-08 2006-12-14 Schering Ag Inhibitoren der löslichen Adenylatzyklase

Also Published As

Publication number Publication date
CN101448787A (zh) 2009-06-03
AR060074A1 (es) 2008-05-21
JP2009530339A (ja) 2009-08-27
DE102006014319B4 (de) 2009-01-08
TW200815348A (en) 2008-04-01
PE20080173A1 (es) 2008-04-30
KR20090008261A (ko) 2009-01-21
CA2646594A1 (en) 2007-09-27
WO2007107384A3 (de) 2007-11-15
US20070259872A1 (en) 2007-11-08
WO2007107384A2 (de) 2007-09-27
DE102006014319A1 (de) 2007-09-27
DOP2007000060A (es) 2007-10-15
EP2001843A2 (de) 2008-12-17

Similar Documents

Publication Publication Date Title
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
EA201170772A1 (ru) Органические соединения
NO20090295L (no) Substituerte heteroarylderivater
CL2007002316A1 (es) Compuestos derivados de pirimidina, inhibidores de pi3k; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en enfermedades proliferativas como cancer.
EA201070519A1 (ru) Соединения тропана
NO20083630L (no) Nye pyridinderivater
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
CR20120634A (es) Derivados de heteroaril imidazolona como inhibidores de jak
ECSP088904A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
EA201170832A1 (ru) Пуриновые соединения
ATE445593T1 (de) Acetylenderivate
GT200800251A (es) Nitrilos espirociclicos como inhibidores de proteasa
PA8657801A1 (es) Aminalcoholes triciclicos, procedimientos para su preparacion
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
EA201000614A1 (ru) Производные пурина как лиганды аденозинового рецептора а
EA201071224A1 (ru) Ингибиторы limk2, композиции, содержащие их, и способы их применения
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
EA200870148A1 (ru) Производные сулиндака, их применение и получение
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
PA8646301A1 (es) Inhibidores de la adenilato ciclasa soluble
EA201000069A1 (ru) Новые гербициды
UY30424A1 (es) Derivados de quinolina, su preparacion, su uso y medicamentos que comprenden los mismos.
UY30235A1 (es) Inhibidores de la adenilato ciclasa soluble
NO20091386L (no) Fenyloksyanilinderivater

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170602